Myeloperoxidase and elastase are only expressed by neutrophils in normal and in inflamed liver, Histochem. Cell Biol, vol.135, pp.305-315, 2011. ,
Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace, J. Hepatol, vol.56, pp.1384-1391, 2012. ,
Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma, Gastroenterology, vol.140, pp.1071-1083, 2011. ,
Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis, Cancer, vol.122, pp.1216-1227, 2016. ,
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease, J. Clin. Invest, vol.115, pp.1343-1351, 2005. ,
Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy, Science, vol.331, pp.456-461, 2011. ,
Molecular classification of hepatocellular carcinoma: potential therapeutic implications, Hepat. Oncol, vol.2, pp.371-379, 2015. ,
AcetylCoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats, Proc. Natl. Acad. Sci. USA, vol.113, pp.1796-1805, 2016. ,
Regulation of hepatic de novo lipogenesis in humans, Annu. Rev. Nutr, vol.16, pp.523-557, 1996. ,
Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment, PLoS One, vol.5, 2010. ,
, , 2009.
, Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma, Cancer Res, vol.69, pp.7385-7392
Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice, Proc. Natl. Acad. Sci. USA, vol.109, pp.4320-4325, 2012. ,
Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes, Hepatology, vol.46, pp.823-830, 2007. ,
Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo, Cancer Res, vol.67, pp.11141-11146, 2007. ,
Dietary fructose enhances the incidence of precancerous hepatocytes induced by administration of diethylnitrosamine in rat, Eur. J. Med. Res, vol.18, p.54, 2013. ,
Sorafenib in advanced hepatocellular carcinoma, SHARP Investigators Study Group, vol.359, pp.378-390, 2008. ,
Hepatocellular carcinoma, Nat. Rev. Dis. Primers, vol.2, p.16018, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01910322
Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonylCoA, J. Biol. Chem, vol.253, pp.4128-4136, 1978. ,
Molecular liver cancer prevention in cirrhosis by organ transcriptome analysis and lysophosphatidic acid pathway inhibition, Precision Liver Cancer Prevention Consortium, vol.30, pp.879-890, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-02312659
Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression, Cell, vol.140, pp.197-208, 2010. ,
Loss of junctional adhesion molecule A promotes severe steatohepatitis in mice on a diet high in saturated fat, fructose, and cholesterol, Gastroenterology, vol.151, pp.733-746, 2016. ,
, , 2013.
, AMPK, insulin resistance, and the metabolic syndrome, J. Clin. Invest, vol.123, pp.2764-2772
Molecular subclasses of hepatocellular carcinoma predict sensitivity to fibroblast growth factor receptor inhibition, Int. J. Cancer, vol.138, pp.1494-1505, 2016. ,
Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models, Nat. Med, vol.22, pp.1108-1119, 2016. ,
Clinicopathological indices to predict hepatocellular carcinoma molecular classification, Liver Int, vol.36, pp.108-118, 2016. ,
Global cancer statistics, CA Cancer J. Clin, vol.65, pp.87-108, 2012. ,
Acetyl-CoA carboxylase-a as a novel target for cancer therapy, Front. Biosci. (Schol. Ed.), vol.2, pp.515-526, 2010. ,
Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma, Eur. J. Cancer, vol.41, pp.1316-1322, 2005. ,
Epithelial-mesenchymal transition predicts sensitivity to the dual IGF-1R/IR inhibitor OSI-906 in hepatocellular carcinoma cell lines, Mol. Cancer Ther, vol.11, pp.503-513, 2012. ,